HEADER VIRAL PROTEIN/IMMUNE SYSTEM 10-JUN-20 6XDG TITLE COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS TITLE 2 OF TWO NEUTRALIZING ANTIBODIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: E; COMPND 4 FRAGMENT: RECEPTOR BINDING DOMAIN (UNP RESIDUES 319-541); COMPND 5 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN,SPIKE GLYCOPROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: REGN10933 ANTIBODY FAB FRAGMENT LIGHT CHAIN; COMPND 9 CHAIN: D; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: REGN10933 ANTIBODY FAB FRAGMENT HEAVY CHAIN; COMPND 13 CHAIN: B; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 4; COMPND 16 MOLECULE: REGN10987 ANTIBODY FAB FRAGMENT HEAVY CHAIN; COMPND 17 CHAIN: C; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 5; COMPND 20 MOLECULE: REGN10987 ANTIBODY FAB FRAGMENT LIGHT CHAIN; COMPND 21 CHAIN: A; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 15 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 22 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 24 MOL_ID: 4; SOURCE 25 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 26 ORGANISM_COMMON: HUMAN; SOURCE 27 ORGANISM_TAXID: 9606; SOURCE 28 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 29 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 30 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 31 MOL_ID: 5; SOURCE 32 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 33 ORGANISM_COMMON: HUMAN; SOURCE 34 ORGANISM_TAXID: 9606; SOURCE 35 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 36 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 37 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS SARS-COV-2, THERAPEUTIC ANTIBODY, ANTIVIRAL, VIRAL PROTEIN-IMMUNE KEYWDS 2 SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR M.C.FRANKLIN,K.SAOTOME,A.ROMERO HERNANDEZ,Y.ZHOU REVDAT 6 27-JAN-21 6XDG 1 COMPND REVDAT 5 02-SEP-20 6XDG 1 JRNL HETSYN REVDAT 4 29-JUL-20 6XDG 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 22-JUL-20 6XDG 1 SOURCE REVDAT 2 08-JUL-20 6XDG 1 REMARK REVDAT 1 24-JUN-20 6XDG 0 JRNL AUTH J.HANSEN,A.BAUM,K.E.PASCAL,V.RUSSO,S.GIORDANO,E.WLOGA, JRNL AUTH 2 B.O.FULTON,Y.YAN,K.KOON,K.PATEL,K.M.CHUNG,A.HERMANN, JRNL AUTH 3 E.ULLMAN,J.CRUZ,A.RAFIQUE,T.HUANG,J.FAIRHURST,C.LIBERTINY, JRNL AUTH 4 M.MALBEC,W.Y.LEE,R.WELSH,G.FARR,S.PENNINGTON,D.DESHPANDE, JRNL AUTH 5 J.CHENG,A.WATTY,P.BOUFFARD,R.BABB,N.LEVENKOVA,C.CHEN, JRNL AUTH 6 B.ZHANG,A.ROMERO HERNANDEZ,K.SAOTOME,Y.ZHOU,M.FRANKLIN, JRNL AUTH 7 S.SIVAPALASINGAM,D.C.LYE,S.WESTON,J.LOGUE,R.HAUPT,M.FRIEMAN, JRNL AUTH 8 G.CHEN,W.OLSON,A.J.MURPHY,N.STAHL,G.D.YANCOPOULOS, JRNL AUTH 9 C.A.KYRATSOUS JRNL TITL STUDIES IN HUMANIZED MICE AND CONVALESCENT HUMANS YIELD A JRNL TITL 2 SARS-COV-2 ANTIBODY COCKTAIL. JRNL REF SCIENCE V. 369 1010 2020 JRNL REFN ESSN 1095-9203 JRNL PMID 32540901 JRNL DOI 10.1126/SCIENCE.ABD0827 REMARK 2 REMARK 2 RESOLUTION. 3.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : EPU, CRYOSPARC, COOT, CRYOSPARC, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : OTHER REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.900 REMARK 3 NUMBER OF PARTICLES : 48140 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 6XDG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1000249983. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX OF SARS-COV-2 SPIKE REMARK 245 PROTEIN RECEPTOR BINDING DOMAIN REMARK 245 WITH FAB FRAGMENTS OF TWO REMARK 245 NEUTRALIZING ANTIBODIES; SPIKE REMARK 245 PROTEIN RECEPTOR BINDING DOMAIN; REMARK 245 REGN10933 ANTIBODY FAB REMARK 245 FRAGMENT; REGN10987 ANTIBODY REMARK 245 FAB FRAGMENT REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 2821 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 40.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 105000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, D, B, C, A, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG E 319 REMARK 465 VAL E 320 REMARK 465 GLN E 321 REMARK 465 PRO E 322 REMARK 465 THR E 323 REMARK 465 GLU E 324 REMARK 465 SER E 325 REMARK 465 ILE E 326 REMARK 465 VAL E 327 REMARK 465 ARG E 328 REMARK 465 PHE E 329 REMARK 465 PRO E 330 REMARK 465 ASN E 331 REMARK 465 ILE E 332 REMARK 465 PRO E 527 REMARK 465 LYS E 528 REMARK 465 LYS E 529 REMARK 465 SER E 530 REMARK 465 THR E 531 REMARK 465 ASN E 532 REMARK 465 LEU E 533 REMARK 465 VAL E 534 REMARK 465 LYS E 535 REMARK 465 ASN E 536 REMARK 465 LYS E 537 REMARK 465 CYS E 538 REMARK 465 VAL E 539 REMARK 465 ASN E 540 REMARK 465 PHE E 541 REMARK 465 GLU E 542 REMARK 465 GLN E 543 REMARK 465 LYS E 544 REMARK 465 LEU E 545 REMARK 465 ILE E 546 REMARK 465 SER E 547 REMARK 465 GLU E 548 REMARK 465 GLU E 549 REMARK 465 ASP E 550 REMARK 465 LEU E 551 REMARK 465 GLY E 552 REMARK 465 GLY E 553 REMARK 465 GLU E 554 REMARK 465 GLN E 555 REMARK 465 LYS E 556 REMARK 465 LEU E 557 REMARK 465 ILE E 558 REMARK 465 SER E 559 REMARK 465 GLU E 560 REMARK 465 GLU E 561 REMARK 465 ASP E 562 REMARK 465 LEU E 563 REMARK 465 HIS E 564 REMARK 465 HIS E 565 REMARK 465 HIS E 566 REMARK 465 HIS E 567 REMARK 465 HIS E 568 REMARK 465 HIS E 569 REMARK 465 SER B 134 REMARK 465 SER B 135 REMARK 465 LYS B 136 REMARK 465 SER B 137 REMARK 465 THR B 138 REMARK 465 SER B 139 REMARK 465 GLY B 140 REMARK 465 GLY B 141 REMARK 465 LYS B 221 REMARK 465 SER B 222 REMARK 465 CYS B 223 REMARK 465 ASP B 224 REMARK 465 LYS B 225 REMARK 465 THR B 226 REMARK 465 SER C 134 REMARK 465 SER C 135 REMARK 465 LYS C 136 REMARK 465 SER C 137 REMARK 465 THR C 138 REMARK 465 SER C 139 REMARK 465 GLY C 140 REMARK 465 GLY C 141 REMARK 465 LYS C 221 REMARK 465 SER C 222 REMARK 465 CYS C 223 REMARK 465 ASP C 224 REMARK 465 LYS C 225 REMARK 465 GLN A 1 REMARK 465 SER A 2 REMARK 465 GLU A 214 REMARK 465 CYS A 215 REMARK 465 SER A 216 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O4 NAG F 1 C2 NAG F 2 1.89 REMARK 500 O6 BMA F 3 O5 MAN F 4 2.11 REMARK 500 OG SER D 121 O PRO B 130 2.13 REMARK 500 O PRO C 130 OG SER A 125 2.13 REMARK 500 O TYR D 186 OH TYR D 192 2.14 REMARK 500 C6 BMA F 3 C1 MAN F 4 2.16 REMARK 500 OG SER D 7 OG1 THR D 22 2.16 REMARK 500 OD1 ASP A 142 NE2 GLN A 171 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN E 360 64.95 60.27 REMARK 500 ASP E 389 58.86 -96.58 REMARK 500 ASN E 422 -35.95 -131.44 REMARK 500 ASN E 450 -60.55 -93.26 REMARK 500 CYS E 488 74.00 58.58 REMARK 500 PHE E 490 132.28 -38.91 REMARK 500 THR D 30 -72.23 -63.22 REMARK 500 LYS D 42 -169.95 -76.72 REMARK 500 ALA D 50 19.33 59.26 REMARK 500 TYR D 140 143.52 -170.53 REMARK 500 LYS D 169 -61.63 -93.14 REMARK 500 SER B 25 148.98 -173.48 REMARK 500 THR B 28 98.36 -69.48 REMARK 500 PHE B 29 -9.54 -57.30 REMARK 500 TYR B 33 -178.58 -68.58 REMARK 500 VAL B 48 -60.82 -121.44 REMARK 500 THR B 103 -80.58 -67.70 REMARK 500 MET B 104 -19.02 -153.58 REMARK 500 ASP B 108 -153.66 -78.50 REMARK 500 TYR B 109 10.25 -51.49 REMARK 500 TRP B 110 129.94 -32.55 REMARK 500 SER B 122 -174.99 -174.42 REMARK 500 SER B 193 5.89 -69.96 REMARK 500 ASN B 211 19.20 58.17 REMARK 500 ALA C 92 -179.64 -171.12 REMARK 500 ASP C 101 -173.18 -69.60 REMARK 500 ASP C 104 -149.05 -151.62 REMARK 500 TYR C 105 -29.21 -39.72 REMARK 500 VAL C 108 -63.31 -126.15 REMARK 500 ASP A 52 -22.69 76.29 REMARK 500 VAL A 53 -67.11 -144.47 REMARK 500 SER A 54 17.10 -147.15 REMARK 500 SER A 95 2.26 -54.19 REMARK 500 PRO A 145 -164.02 -76.09 REMARK 500 LYS A 160 21.91 -140.03 REMARK 500 ASN A 173 32.03 -91.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-22137 RELATED DB: EMDB REMARK 900 COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB REMARK 900 FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES DBREF 6XDG E 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 DBREF 6XDG D 1 214 PDB 6XDG 6XDG 1 214 DBREF 6XDG B 1 226 PDB 6XDG 6XDG 1 226 DBREF 6XDG C 1 225 PDB 6XDG 6XDG 1 225 DBREF 6XDG A 1 216 PDB 6XDG 6XDG 1 216 SEQADV 6XDG GLU E 542 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLN E 543 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG LYS E 544 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG LEU E 545 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG ILE E 546 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG SER E 547 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLU E 548 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLU E 549 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG ASP E 550 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG LEU E 551 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLY E 552 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLY E 553 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLU E 554 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLN E 555 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG LYS E 556 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG LEU E 557 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG ILE E 558 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG SER E 559 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLU E 560 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG GLU E 561 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG ASP E 562 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG LEU E 563 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG HIS E 564 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG HIS E 565 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG HIS E 566 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG HIS E 567 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG HIS E 568 UNP P0DTC2 EXPRESSION TAG SEQADV 6XDG HIS E 569 UNP P0DTC2 EXPRESSION TAG SEQRES 1 E 251 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 E 251 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 3 E 251 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 E 251 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 5 E 251 SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 6 E 251 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 E 251 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 8 E 251 ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN SEQRES 9 E 251 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 E 251 TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN SEQRES 11 E 251 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 12 E 251 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 E 251 ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN SEQRES 14 E 251 CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR SEQRES 15 E 251 ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 E 251 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 E 251 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 E 251 ASN PHE GLU GLN LYS LEU ILE SER GLU GLU ASP LEU GLY SEQRES 19 E 251 GLY GLU GLN LYS LEU ILE SER GLU GLU ASP LEU HIS HIS SEQRES 20 E 251 HIS HIS HIS HIS SEQRES 1 D 214 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 D 214 SER VAL GLY ASP ARG VAL THR ILE THR CYS GLN ALA SER SEQRES 3 D 214 GLN ASP ILE THR ASN TYR LEU ASN TRP TYR GLN GLN LYS SEQRES 4 D 214 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ALA ALA SER SEQRES 5 D 214 ASN LEU GLU THR GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 D 214 GLY SER GLY THR ASP PHE THR PHE THR ILE SER GLY LEU SEQRES 7 D 214 GLN PRO GLU ASP ILE ALA THR TYR TYR CYS GLN GLN TYR SEQRES 8 D 214 ASP ASN LEU PRO LEU THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 D 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 D 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 D 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 D 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 D 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 D 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 D 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 D 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 D 214 PHE ASN ARG GLY GLU CYS SEQRES 1 B 226 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 B 226 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 226 PHE THR PHE SER ASP TYR TYR MET SER TRP ILE ARG GLN SEQRES 4 B 226 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER TYR ILE THR SEQRES 5 B 226 TYR SER GLY SER THR ILE TYR TYR ALA ASP SER VAL LYS SEQRES 6 B 226 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS SER SER SEQRES 7 B 226 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 B 226 ALA VAL TYR TYR CYS ALA ARG ASP ARG GLY THR THR MET SEQRES 9 B 226 VAL PRO PHE ASP TYR TRP GLY GLN GLY THR LEU VAL THR SEQRES 10 B 226 VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 B 226 LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA SEQRES 12 B 226 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 B 226 VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY SEQRES 14 B 226 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 B 226 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 B 226 LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS SEQRES 17 B 226 PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 18 B 226 SER CYS ASP LYS THR SEQRES 1 C 225 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 C 225 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 C 225 PHE THR PHE SER ASN TYR ALA MET TYR TRP VAL ARG GLN SEQRES 4 C 225 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA VAL ILE SER SEQRES 5 C 225 TYR ASP GLY SER ASN LYS TYR TYR ALA ASP SER VAL LYS SEQRES 6 C 225 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 C 225 LEU TYR LEU GLN MET ASN SER LEU ARG THR GLU ASP THR SEQRES 8 C 225 ALA VAL TYR TYR CYS ALA SER GLY SER ASP TYR GLY ASP SEQRES 9 C 225 TYR LEU LEU VAL TYR TRP GLY GLN GLY THR LEU VAL THR SEQRES 10 C 225 VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 C 225 LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA SEQRES 12 C 225 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 C 225 VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY SEQRES 14 C 225 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 C 225 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 C 225 LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS SEQRES 17 C 225 PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 18 C 225 SER CYS ASP LYS SEQRES 1 A 216 GLN SER ALA LEU THR GLN PRO ALA SER VAL SER GLY SER SEQRES 2 A 216 PRO GLY GLN SER ILE THR ILE SER CYS THR GLY THR SER SEQRES 3 A 216 SER ASP VAL GLY GLY TYR ASN TYR VAL SER TRP TYR GLN SEQRES 4 A 216 GLN HIS PRO GLY LYS ALA PRO LYS LEU MET ILE TYR ASP SEQRES 5 A 216 VAL SER LYS ARG PRO SER GLY VAL SER ASN ARG PHE SER SEQRES 6 A 216 GLY SER LYS SER GLY ASN THR ALA SER LEU THR ILE SER SEQRES 7 A 216 GLY LEU GLN SER GLU ASP GLU ALA ASP TYR TYR CYS ASN SEQRES 8 A 216 SER LEU THR SER ILE SER THR TRP VAL PHE GLY GLY GLY SEQRES 9 A 216 THR LYS LEU THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SEQRES 10 A 216 SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 A 216 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 A 216 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SEQRES 13 A 216 SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER SEQRES 14 A 216 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 A 216 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 A 216 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 A 216 THR VAL ALA PRO THR GLU CYS SER HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 6 NAG 2(C8 H15 N O6) FORMUL 6 BMA C6 H12 O6 FORMUL 6 MAN C6 H12 O6 HELIX 1 AA1 PRO E 337 ASN E 343 1 7 HELIX 2 AA2 TYR E 365 ASN E 370 1 6 HELIX 3 AA3 SER E 383 ASP E 389 1 7 HELIX 4 AA4 ASP E 405 ILE E 410 5 6 HELIX 5 AA5 GLY E 416 ASN E 422 1 7 HELIX 6 AA6 SER D 121 GLY D 128 1 8 HELIX 7 AA7 LYS D 183 HIS D 189 1 7 HELIX 8 AA8 THR B 28 TYR B 32 5 5 HELIX 9 AA9 ARG B 87 THR B 91 5 5 HELIX 10 AB1 PRO B 192 LEU B 196 5 5 HELIX 11 AB2 THR C 28 TYR C 32 5 5 HELIX 12 AB3 ARG C 87 THR C 91 5 5 HELIX 13 AB4 PRO C 192 LEU C 196 5 5 HELIX 14 AB5 SER A 125 GLN A 130 1 6 HELIX 15 AB6 THR A 185 HIS A 192 1 8 SHEET 1 AA1 5 ASN E 354 ILE E 358 0 SHEET 2 AA1 5 ASN E 394 ARG E 403 -1 O ALA E 397 N LYS E 356 SHEET 3 AA1 5 PRO E 507 GLU E 516 -1 O VAL E 512 N ASP E 398 SHEET 4 AA1 5 CYS E 432 ASN E 437 -1 N CYS E 432 O LEU E 513 SHEET 5 AA1 5 THR E 376 CYS E 379 -1 N LYS E 378 O VAL E 433 SHEET 1 AA2 2 LEU E 452 TYR E 453 0 SHEET 2 AA2 2 GLN E 493 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AA3 4 MET D 4 SER D 7 0 SHEET 2 AA3 4 VAL D 19 ALA D 25 -1 O THR D 22 N SER D 7 SHEET 3 AA3 4 ASP D 70 ILE D 75 -1 O PHE D 71 N CYS D 23 SHEET 4 AA3 4 PHE D 62 SER D 67 -1 N SER D 65 O THR D 72 SHEET 1 AA4 4 ASN D 53 LEU D 54 0 SHEET 2 AA4 4 LYS D 45 TYR D 49 -1 N TYR D 49 O ASN D 53 SHEET 3 AA4 4 LEU D 33 GLN D 38 -1 N TRP D 35 O LEU D 47 SHEET 4 AA4 4 THR D 85 GLN D 90 -1 O TYR D 87 N TYR D 36 SHEET 1 AA5 4 SER D 114 PHE D 118 0 SHEET 2 AA5 4 THR D 129 PHE D 139 -1 O LEU D 135 N PHE D 116 SHEET 3 AA5 4 TYR D 173 SER D 182 -1 O LEU D 181 N ALA D 130 SHEET 4 AA5 4 SER D 159 VAL D 163 -1 N SER D 162 O SER D 176 SHEET 1 AA6 4 ALA D 153 GLN D 155 0 SHEET 2 AA6 4 LYS D 145 VAL D 150 -1 N VAL D 150 O ALA D 153 SHEET 3 AA6 4 VAL D 191 THR D 197 -1 O GLU D 195 N GLN D 147 SHEET 4 AA6 4 THR D 206 ASN D 210 -1 O PHE D 209 N TYR D 192 SHEET 1 AA7 4 GLN B 3 GLU B 6 0 SHEET 2 AA7 4 SER B 17 SER B 25 -1 O ALA B 23 N VAL B 5 SHEET 3 AA7 4 SER B 78 ASN B 84 -1 O LEU B 81 N LEU B 20 SHEET 4 AA7 4 PHE B 68 SER B 71 -1 N THR B 69 O GLN B 82 SHEET 1 AA8 4 ILE B 58 TYR B 60 0 SHEET 2 AA8 4 LEU B 45 ILE B 51 -1 N TYR B 50 O TYR B 59 SHEET 3 AA8 4 TYR B 33 GLN B 39 -1 N ARG B 38 O GLU B 46 SHEET 4 AA8 4 ALA B 97 ASP B 99 -1 O ALA B 97 N SER B 35 SHEET 1 AA9 2 ALA B 92 TYR B 94 0 SHEET 2 AA9 2 THR B 114 VAL B 116 -1 O VAL B 116 N ALA B 92 SHEET 1 AB1 4 SER B 127 LEU B 131 0 SHEET 2 AB1 4 ALA B 143 LYS B 150 -1 O LEU B 148 N PHE B 129 SHEET 3 AB1 4 TYR B 183 VAL B 191 -1 O VAL B 189 N LEU B 145 SHEET 4 AB1 4 VAL B 170 LEU B 177 -1 N PHE B 173 O SER B 186 SHEET 1 AB2 2 THR B 158 TRP B 161 0 SHEET 2 AB2 2 CYS B 203 ASN B 206 -1 O ASN B 204 N SER B 160 SHEET 1 AB3 4 GLN C 3 GLU C 6 0 SHEET 2 AB3 4 LEU C 18 SER C 25 -1 O ALA C 23 N VAL C 5 SHEET 3 AB3 4 THR C 78 MET C 83 -1 O LEU C 81 N LEU C 20 SHEET 4 AB3 4 PHE C 68 SER C 71 -1 N SER C 71 O TYR C 80 SHEET 1 AB4 5 LYS C 58 TYR C 60 0 SHEET 2 AB4 5 LEU C 45 ILE C 51 -1 N VAL C 50 O TYR C 59 SHEET 3 AB4 5 MET C 34 GLN C 39 -1 N ARG C 38 O GLU C 46 SHEET 4 AB4 5 ALA C 92 CYS C 96 -1 O TYR C 95 N VAL C 37 SHEET 5 AB4 5 THR C 114 VAL C 116 -1 O THR C 114 N TYR C 94 SHEET 1 AB5 3 SER C 127 LEU C 131 0 SHEET 2 AB5 3 ALA C 144 TYR C 152 -1 O LEU C 148 N PHE C 129 SHEET 3 AB5 3 TYR C 183 THR C 190 -1 O LEU C 185 N VAL C 149 SHEET 1 AB6 2 VAL C 205 ASN C 206 0 SHEET 2 AB6 2 LYS C 213 VAL C 214 -1 O VAL C 214 N VAL C 205 SHEET 1 AB7 2 SER A 9 GLY A 12 0 SHEET 2 AB7 2 LYS A 106 VAL A 109 1 O THR A 108 N VAL A 10 SHEET 1 AB8 3 SER A 17 THR A 23 0 SHEET 2 AB8 3 THR A 72 SER A 78 -1 O ALA A 73 N CYS A 22 SHEET 3 AB8 3 PHE A 64 SER A 69 -1 N SER A 67 O SER A 74 SHEET 1 AB9 4 LYS A 47 TYR A 51 0 SHEET 2 AB9 4 SER A 36 GLN A 40 -1 N TRP A 37 O ILE A 50 SHEET 3 AB9 4 ASP A 87 SER A 92 -1 O ASN A 91 N SER A 36 SHEET 4 AB9 4 VAL A 100 PHE A 101 -1 O VAL A 100 N SER A 92 SHEET 1 AC1 4 SER A 118 PHE A 122 0 SHEET 2 AC1 4 THR A 135 PHE A 143 -1 O SER A 141 N SER A 118 SHEET 3 AC1 4 TYR A 176 ALA A 178 -1 O TYR A 176 N PHE A 143 SHEET 4 AC1 4 SER A 169 LYS A 170 -1 N SER A 169 O ALA A 177 SHEET 1 AC2 3 SER A 118 PHE A 122 0 SHEET 2 AC2 3 THR A 135 PHE A 143 -1 O SER A 141 N SER A 118 SHEET 3 AC2 3 LEU A 182 SER A 183 -1 O LEU A 182 N LEU A 136 SHEET 1 AC3 4 PRO A 158 VAL A 159 0 SHEET 2 AC3 4 THR A 149 LYS A 153 -1 N TRP A 152 O VAL A 159 SHEET 3 AC3 4 TYR A 195 THR A 200 -1 O SER A 196 N LYS A 153 SHEET 4 AC3 4 GLU A 207 VAL A 210 -1 O LYS A 208 N CYS A 197 SSBOND 1 CYS E 336 CYS E 361 1555 1555 2.03 SSBOND 2 CYS E 379 CYS E 432 1555 1555 2.04 SSBOND 3 CYS E 391 CYS E 525 1555 1555 2.03 SSBOND 4 CYS D 134 CYS D 194 1555 1555 2.03 SSBOND 5 CYS B 22 CYS B 96 1555 1555 2.03 SSBOND 6 CYS B 147 CYS B 203 1555 1555 2.03 SSBOND 7 CYS C 22 CYS C 96 1555 1555 2.03 SSBOND 8 CYS C 147 CYS C 203 1555 1555 2.03 SSBOND 9 CYS A 22 CYS A 90 1555 1555 2.03 SSBOND 10 CYS A 138 CYS A 197 1555 1555 2.03 LINK ND2 ASN E 343 C1 NAG F 1 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.37 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.37 LINK O6 BMA F 3 C1 MAN F 4 1555 1555 1.38 CISPEP 1 SER D 7 PRO D 8 0 -1.16 CISPEP 2 TYR D 140 PRO D 141 0 0.66 CISPEP 3 PHE B 153 PRO B 154 0 -6.38 CISPEP 4 GLU B 155 PRO B 156 0 -0.60 CISPEP 5 PHE C 153 PRO C 154 0 -3.58 CISPEP 6 GLU C 155 PRO C 156 0 -7.83 CISPEP 7 TYR A 144 PRO A 145 0 -1.23 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000